Faculty

Steve Schwartz

Professor, Epidemiology


Education

PhD Epidemiology, University of Washington, 1990
MPH Epidemiology, Yale University, 1984

Contact


University of Washington
Box 351619
Department of Epidemiology
Hans Rosling Center for Population Health, 861B
Seattle, WA 98195

Research Areas

Research Interests

Dr. Schwartz primarily studies the etiology and outcomes of cancer. A major objective of his research is to determine the influence of genetic susceptibility, either alone or in combination with lifestyle and environmental risk factors. Current funded research projects include studies focusing on the genetic and non-genetic risk factors for HPV-cancers and testicular germ cell tumors. Other areas of cancer research focus on molecular markers for oral cancer outcomes and the health and well-being of adolescent and young adult cancer survivors. Among his other responsibilities in the field of cancer epidemiology, he serves as Principal Investigator of the Cancer Surveillance System, a population-based cancer registry at the Fred Hutchinson Cancer Research Center.

Recent Publications (PubMed)

Epigenetic aging and transposon dysregulation reflect size-related lifespan compression in dogs.
(2026 Oct 8)
Science 394(6820): eaeb2986
Mariner BL, McCoy BM, Greenier A, Brassington L, Slikas E, Adjangba C, Cheng C, Marye A, Harrison BR, Bamberger T, Algavi Y, Muller E, Harris A, Rout E, Reichel C, Sohrab V, Dog Aging Project Consortium‡, Karlsson E, Akey JM, Avery AC, Borenstein E, Promislow DEL, Snyder-Mackler N, Akey JM, Anderson RM, Borenstein E, Castelhano MG, Coleman AE, Creevy KE, Dunbar MD, Fajt VR, Hoffman JM, Jonlin EC, Kaeberlein M, Karlsson EK, Kerr KF, Ma J, MacLean EL, McGrath S, Olby NJ, Promislow DEL, Reed MJ, Ruple A, Schwartz SM, Shrager S, Snyder-Mackler N, Tolbert MK
Court-Documented Adverse Financial Events Before Cancer Diagnosis and Mortality Risk.
(2026 Oct 1)
JAMA Netw Open 9(10): e2637677
Yabroff KR, Noone AM, Mariotto A, Shankaran V, Ward KC, Schwartz SM, Wu XC, Warren JL
Weighted epigenetic site correlation network analysis of chemotherapy impacts on osteosarcoma cancer survivors' male fertility, sperm, and endocrine parameters.
(2026)
Environ Epigenet 12(1): dvag029
Shnorhavorian M, Amory JK, Schwartz SM, Bhatia S, Armenian S, Grier HE, Chow EJ, Joshi R, Beck D, Skinner MK
Risk of Head and Neck Cancer in Former Smokers by Subsite: A Multicenter Analysis From the INHANCE Consortium.
(2026 Sep 1)
Int J Cancer 159(5): 1204-1217
de Abreu M, Kowalski LP, López RM, Barul C, Radoi L, Bidoli E, Polesel J, Wunsch-Filho V, Olshan AF, Zevallos J, Negri E, Edefonti V, Świątkowska B, Mates D, Fabianova E, Lissowska J, Shangina O, Brennan P, Pandics T, Maso LD, Morgenstern H, Zhang ZF, Kelsey K, McClean M, La Vecchia C, Garavello W, Chen C, Schwartz SM, Ramroth H, Winkler V, Cadoni G, Boccia S, Brenner H, D'Souza G, Gross N, Muscat J, Abedini M, Sassano M, Boffetta P, Hashibe M, Lee YA, Curado MP
The Testicular Cancer Consortium (TECAC): Filling Knowledge Gaps in the Genetic Etiology of Testicular Germ Cell Tumors.
(2026 Jan 4)
Andrology
Kanetsky PA, Almstrup K, Cherlin S, Cortessis VK, Ferlin A, Gietema JA, González-Neira A, Grotmol T, Hamilton RJ, Haugen TB, Kiemeney LA, Kim J, Krausz C, Lessel D, Lothe RA, Nead KT, Nsengimana J, Poynter JN, Rajpert-DeMeyts E, Richiardi L, Schwartz SM, Skotheim RI, Stewart DR, Turnbull C, Wiklund F, Zheng T, Nathanson KL, McGlynn KA, Testicular Cancer Consortium
Show complete publication list